DeDora Capital’s BioNTech BNTX Stock Holding History

DeDora Capital’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-299	Closed	-$51K	–	141
2022 Q1	$51K	Buy	+299	New	+$50.2K	0.02%	160

Other funds holding BNTX

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

DeDora Capital's BNTX Position: Q2 2022 in Review

DeDora Capital sold out of BioNTech (BNTX) in Q2 2022, closing a stake of 299 shares — an estimated $51K sold.

DeDora Capital first reported a position in BNTX in Q1 2022 and held it in 1 quarter. The position peaked at $51K in Q1 2022. 293 funds tracked by Wall St. Rank hold BNTX as of Q2 2022.

DeDora Capital reported no remaining BioNTech position as of Q2 2022 after selling out during the quarter.
DeDora Capital sold 299 BioNTech shares in Q2 2022, an estimated $51K.
DeDora Capital first reported a position in BioNTech in Q1 2022 and held it in 1 quarter.
DeDora Capital's BioNTech position peaked at $51K in Q1 2022.
293 funds tracked by Wall St. Rank held BioNTech as of Q2 2022.

Based on DeDora Capital's 13F filing for Q2 2022, filed 27 Jul 2022.